. Protein degradation profile of VHL-based BET degraders. Sub-confluent HeLa cells were treated for 24 h with varying concentration of test compounds (a, b) MZP-61; (c, d) MZP-54; (e, f) MZ4; (g, h) MZ1; (i, j) ARV-825; (k, l) I-BET726; and (m, n) JQ1. Protein extracts were separated by SDS-PAGE and then analyzed by Western blot. Proteins Brd4, Brd3, Brd2 and β-actin were probed for (a, c, e, g, i, k and m) with specific antibodies. Band intensity of BET proteins were normalized to vehicle treatment (0.1% DMSO), adjusted to band intensity of β-actin, and plotted (b, d, f, h, j, l and n) (a,c, e, g,i) and quantified relative to DMSO control (b,d,f, h,j) . Intensity values were quan-tified as described in the Methods. Titrations were performed at 25°C in duplicate except for VCB into 10, which was performed in quadruplicate.
SUPPLEMENTARY TABLES
Values reported are the mean ± s.e.m. 
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